(2Z)-3-[3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid, 98%, 50mg

(2S,4S,5S)-1-(3,5-Di-tert-butylphenyl)-3-(2-methylnaphthalen-1-yl)-4,5-diphenyl-1,3,2-diazaphospholidine 2-oxide, 50mg

5-Chloro-3-methyl-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one, 98%, 100mg

Ga piezas 99,9999% 50 g

3,5-Bis(trifluoromethyl)benzyl Chloride>97.0%(GC)25g

7-Hydroxy-4-(trifluoromethyl)coumarin>98.0%(HPLC)(T)5g

2-(1H-PYRAZOL-3-YL)ETHANOL, 95.0%, 250mg

n-dodecano, mínimo 95 %, para síntesis, 500 ml, envase de vidrio

Fosfato de magnesio hidrato en polvo 5 g

Bromo(methanesulfonyl)methane, 97%, 250mg

1,3-Bis(4-(trifluoromethyl)phenyl)urea, 97%, 100mg

3,5-Dimethoxyphenol, 98.0%, 100g

2-amino-6-(hydroxymethyl)-1,4-dihydropteridin-4-one, 98%, 250mg